Learn more

ADVANCIS PHARMACEUTICAL CORP

Overview
  • Total Patents
    64
About

ADVANCIS PHARMACEUTICAL CORP has a total of 64 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are STRIDES ARCOLAB LTD, CO ENZYME TECHNOLOGY LTD and CMP DEV LLC.

Patent filings in countries

World map showing ADVANCIS PHARMACEUTICAL CORPs patent filings in countries

Patent filings per year

Chart showing ADVANCIS PHARMACEUTICAL CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rudnic Edward M 37
#2 Wassink Sandra E 36
#3 Isbister James D 30
#4 Treacy Jr Donald J 24
#5 Burnside Beth A 23
#6 Flanner Henry H 20
#7 Treacy Donald J Jr 9
#8 Treacy Donald 9
#9 Rowlings Colin 8
#10 Tolle-Sander Sanna 6

Latest patents

Publication Filing date Title
AU2006332851A1 Gastric release pulse system for drug delivery
CN101563466A Modified release amoxicillin products
CA2635606A1 Modified release amoxicillin products
WO2006105350A1 Pharmaceutical tablet and apparatus and method for making
WO2006014427A1 Tablet for pulsed delivery
EP1701705A2 Enhanced absorption of modified release dosage forms
CA2538064A1 Antibiotic product, use and formulation thereof
WO2005016311A1 Robust pellet
WO2005009365A2 Antibiotic product, use and formulation thereof
US6991807B2 Antibiotic composition
EP1487414A2 Antibiotic composition
US6929804B2 Anti-fungal composition
US7108859B2 Antineoplastic product, use and formulation thereof
US7074417B2 Multiple-delayed release anti-viral product, use and formulation thereof
US7025989B2 Multiple-delayed released antibiotic product, use and formulation thereof
US7157095B2 Multiple-delayed release antifungal product, use and formulation thereof
US7105174B2 Multiple-delayed release anti-neoplastic product, use and formulation thereof
US6627222B2 Amoxicillin-dicloxacillin antibiotic composition
US6623758B2 Cephalosporin-metronidazole antibiotic composition
US6638532B2 Tetracycline—doxycycline antibiotic composition